Go to main content

University of Silesia in Katowice

  • Polski
  • English

Nanomedicine | A new patent to fight pancreatic cancer

20.01.2022 - 09:58 update 19.04.2022 - 11:48
Editors: MK
Tags: nauki chemiczne

Thanks to the intensive development of nanomedicine, we are getting better and better medicinal substances used in anticancer therapies. Of particular interest are also new drug delivery methods employing different pharmaceutical carriers. An interesting example of such a carrier can be a derivative of [60]fullerene, containing both a carboxyl group and a hydroxyl group in its structure. Thanks to such properties as water solubility or the ability to cross cell membranes, it can be successfully used in biology and medicine. By acting as a drug carrier, it will work mainly in the case of pharmaceutical substances with amino or hydroxyl groups in their structure. Such compounds have great potential in the treatment of pancreatic cancer, which belongs to the group of particularly difficult to treat and aggressive neoplasms. The derivative of [60]fullerene and the method of its preparation are covered by patent protection.

The authors of the invention are scientists from the Faculty of Science and Technology of the University of Silesia in Katowice: Maciej Serda, PhD Eng. Paweł Nalepa, MA, and Prof. Robert Musioł.

You can read more about nanomedicine in anti-cancer therapies, among others in the article presenting the research of Maciej Serda, PhD Eng, published in the Silesian research.


return to top